Determining
the levels of glycated hemoglobin gives assurance to healthcare
practitioners about decision making on the treatment to be prescribed
to diabetic patients. Such tests are primarily used for diagnosis and
monitoring of hemoglobin A1c levels. Hemoglobin A1c test provides the
average amount of patient’s glucose levels in last 2 to 3 months,
therefore, it is preferred over other conventionally used blood
glucose tests. Due to this reason, medical practitioners are
increasingly recommending hemoglobin A1c testing devices over glucose
testing devices to diabetic patients which has lead to increased use
of hemoglobin A1c testing devices.
This
study covers the market analysis for various technologies and
end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders
for this report include manufacturers of hemoglobin A1C testing
analyzers, research organizations involved in developing new and
innovative technologies for hemoglobin A1c testing devices and the
new players who wish to enter this market. The report consists of
executive summary, which provides the market snapshot containing the
information of segments of hemoglobin A1c testing devices market.
This section also includes the comparative analysis of hemoglobin A1c
market based on different geographical regions.
Browse
Market Research
Report:
http://www.transparencymarketresearch.com/hemoglobin-a1c-testing.html
http://www.transparencymarketresearch.com/hemoglobin-a1c-testing.html
Hemoglobin
A1c Testing Devices Market: Segments
Testing
the levels of glycated hemoglobin provides an assurance to the
healthcare practitioner about the patient’s blood glucose level.
This test can be used for diagnosis and monitoring of hemoglobin A1c
levels in diabetic patients. Since A1C test reflects the average
amount of glucose for the past 2 to 3 months, it is opined to be more
reliable than conventional blood glucose test. Physicians are
increasingly prescribing HbA1c test to their patients which will lead
to an increase in the test volume. Moreover, rising diabetes
incidence rate is a major driver for the HbA1c testing market. With
growing awareness about prevention and management of diabetes, the
demand for HbA1c testing devices will rise rapidly especially in the
Asia-Pacific, Latin America, MiddleEast and African regions.
Moreover,
advent of these devices for the diagnosis of diabetes will further
bolster the demand for these devices in future. For instance,
approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in
2013and Abbott’s ARCHITECT Clinical Chemistry Hemoglobin A1c
(HbA1c) test approved in 2014 for the diagnosis of diabetes were the
major steps in the hemoglobin A1c testing industry. With this
diagnostic tools, physicians can combat the rising incidence of
diabetes with timely and appropriate actions in identifying and
managing diabetes.
Based
on the end-use, the global hemoglobin A1c testing devices market is
categorized into two segments namely laboratory testing and
point-of-care (POC) testing devices. Laboratory testing devices held
the majority share of the market in 2012, while the global market for
point-of-care testing devices is expected to grow at a faster
paceduring the forecast period.
Fill
the form for an exclusive sample of this report:
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
No comments:
Post a Comment